Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-16-013622

Director acquired 14,403 shares (option exercise)

  • Director gave 7,202 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

TARNOW MICHAEL M · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-12-12 Exercise or conversion : show line 1 in the form +14,403 $3.21 $46,234 69,570 D
2016-12-12 Gift : show line 2 in the form −7,202 62,368 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-12-12 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −14,403 $3.21 2016-12-31 14,403 0 D
Loading xslF345X03/formfour.xml…